Trademark: 86349919
Word
BREZULTA
Status
Dead
Status Code
710
Status Date
Friday, December 3, 2021
Serial Number
86349919
Registration Number
4738018
Registration Date
Tuesday, May 19, 2015
Mark Type
4000
Filing Date
Monday, July 28, 2014
Published for Opposition
Tuesday, March 3, 2015
Cancellation Date
Friday, December 3, 2021

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Events
Dec 3, 2021
Cancelled Sec. 8 (6-Yr)
May 19, 2020
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jun 22, 2015
Teas Change Of Correspondence Received
May 19, 2015
Registered-Principal Register
Mar 3, 2015
Official Gazette Publication Confirmation E-Mailed
Mar 3, 2015
Published For Opposition
Feb 11, 2015
Notification Of Notice Of Publication E-Mailed
Jan 26, 2015
Law Office Publication Review Completed
Jan 22, 2015
Approved For Pub - Principal Register
Jan 21, 2015
Data Modification Completed
Jan 20, 2015
Teas/Email Correspondence Entered
Jan 20, 2015
Correspondence Received In Law Office
Jan 12, 2015
Assigned To Lie
Jan 7, 2015
Teas Response To Suspension Inquiry Received
Nov 10, 2014
Notification Of Letter Of Suspension E-Mailed
Nov 10, 2014
Letter Of Suspension E-Mailed
Nov 10, 2014
Suspension Letter Written
Nov 10, 2014
Assigned To Examiner
Aug 5, 2014
New Application Office Supplied Data Entered In Tram
Jul 31, 2014
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24